Related references
Note: Only part of the references are listed.Mitochondrial Genomics and Antiretroviral Therapy-Associated Metabolic Complications in HIV-Infected Black South Africans: A Pilot Study
Phumla Z. Sinxadi et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV
Damien V. Cordery et al.
AIDS (2012)
Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy
Andrea De Luca et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi
Joep J. van Oosterhout et al.
PLOS ONE (2012)
A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects
Colin N. Menezes et al.
BMC INFECTIOUS DISEASES (2011)
Validated primer set that prevents nuclear DNA sequences of mitochondrial origin co-amplification: A revision based on the New Human Genome Reference Sequence (GRCh37)
Amanda Ramos et al.
ELECTROPHORESIS (2011)
Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD)
Sang Hoon Han et al.
ENDOCRINE JOURNAL (2011)
Association between HLA-B☆4001 and Lipodystrophy among HIV-Infected Patients from Thailand Who Received a Stavudine-Containing Antiretroviral Regimen
Wittaya Wangsomboonsiri et al.
CLINICAL INFECTIOUS DISEASES (2010)
Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)-Associated Lipodystrophy Syndrome and Stavudine-Triphosphate Intracellular Levels in Patients with Stavudine-Based Antiretroviral Regimens
Pere Domingo et al.
CLINICAL INFECTIOUS DISEASES (2010)
Human mitochondrial DNA complete amplification and sequencing: A new validated primer set that prevents nuclear DNA sequences of mitochondrial origin co-amplification
Amanda Ramos et al.
ELECTROPHORESIS (2009)
Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy
Sher L. Hendrickson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda
Johan van Griensven et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2007)
Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
S Grinspoon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection
PY Hsue et al.
CIRCULATION (2004)
Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients
B Lindegaard et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
A Carr et al.
LANCET (2003)
Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy
MC Uccelli et al.
AIDS (2003)
Goodpasture syndrome during the course of a Schonlein-Henoch purpura:
L Carreras et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs:: actors or bystanders?
A Cossarizza et al.
BIOESSAYS (2001)
Share Paper
